AWM
ANGO icon

Aevitas Wealth Management’s AngioDynamics ANGO Stock Holding History

Aevitas Wealth Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-40
Closed -$1K – 434
2018
Q1 		$1K Hold
40
– – ﹤0.01% 420
2017
Q4 		$1K Buy
+40
New +$683 ﹤0.01% 411

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Aevitas Wealth Management's ANGO Position: Q2 2018 in Review

Aevitas Wealth Management sold out of AngioDynamics (ANGO) in Q2 2018, closing a stake of 40 shares — an estimated $1K sold.

Aevitas Wealth Management first reported a position in ANGO in Q4 2017 and held it in 2 quarters. The position peaked at $1K in Q1 2018. 174 funds tracked by Wall St. Rank hold ANGO as of Q2 2018.

  • Aevitas Wealth Management reported no remaining AngioDynamics position as of Q2 2018 after selling out during the quarter.
  • Aevitas Wealth Management sold 40 AngioDynamics shares in Q2 2018, an estimated $1K.
  • Aevitas Wealth Management first reported a position in AngioDynamics in Q4 2017 and held it in 2 quarters.
  • Aevitas Wealth Management's AngioDynamics position peaked at $1K in Q1 2018.
  • 174 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2018.

Based on Aevitas Wealth Management's 13F filing for Q2 2018, filed 10 Aug 2018.